| Literature DB >> 31692514 |
Valentina Mascaro1, Lorena Squillace1, Carmelo Ga Nobile2, Rosa Papadopoli1, Thijs Bosch3, Leo M Schouls3, Francesco Casalinuovo4, Rosanna Musarella4, Maria Pavia1.
Abstract
PURPOSE: We conducted a cross-sectional study to measure the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) colonization, with a particular focus on livestock associated (LA)-MRSA in farmers working in contact with livestock (sheep) in one Italian region. Furthermore, we have assessed the antimicrobial resistance pattern of isolates and the association of carriage with specific characteristic of farms and working tasks. PATIENTS AND METHODS: Demographic data, occupational history, and contact with animals information was collected. Nasal and oropharyngeal swabs were collected and all samples were tested for the isolation and identification of S. aureus. Isolates were examined for antimicrobial susceptibility and all MRSA strains underwent molecular analyses through multiple-locus variable number of tandem repeat analysis (MLVA).Entities:
Keywords: antimicrobial resistance; colonization; epidemiology; methicillin-resistant Staphylococcus aureus; sheep farmers
Year: 2019 PMID: 31692514 PMCID: PMC6708399 DOI: 10.2147/IDR.S211629
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Characteristics of workers (N=275)
| N (%) | |
|---|---|
| Male | 227 (82.6) |
| Female | 48 (17.4) |
| ≤45 | 142 (51.6) |
| >45 | 133 (48.4) |
| Married/cohabitees | 192 (70.1) |
| Other | 82 (29.9) |
| <8 | 256 (93.4) |
| ≥8 | 18 (6.6) |
| Italian | 249 (90.5) |
| Other | 26 (9.5) |
| Yes | 198 (72.3) |
| No | 76 (27.7) |
| ≤25 | 154 (56) |
| >25 | 121 (44) |
| ≤40 | 98 (35.6) |
| >40 | 177 (64.4) |
| ≤4 | 26 (9.5) |
| >4 | 248 (90.5) |
| <9 | 146 (53.3) |
| ≥9 | 128 (46.7) |
| Yes | 229 (83.6) |
| No | 45 (16.4) |
| Yes | 221 (80.7) |
| No | 53 (19.3) |
| Yes | 158 (57.7) |
| No | 116 (42.3) |
| Yes | 181 (66.1) |
| No | 93 (33.9) |
| Yes | 221 (80.7) |
| No | 53 (19.3) |
| Yes | 217 (79.2) |
| No | 57 (20.8) |
| Yes | 108 (39.4) |
| No | 166 (60.6) |
| Yes | 75 (27.4) |
| No | 199 (72.6) |
| Yes | 207 (76.4) |
| No | 64 (23.6) |
| Yes | 252 (92) |
| No | 22 (8) |
| More than once a month | 10 (3.6) |
| More than once a week | 137 (50) |
| Daily | 127 (46.4) |
| Yes | 34 (12.4) |
| No | 240 (87.6) |
| Yes | 62 (22.6) |
| No | 212 (77.4) |
| Yes | 95 (34.7) |
| No | 179 (65.3) |
| Yes | 20 (7.3) |
| No | 254 (92.7) |
Notes: aTotal may not always sum to “N” because of missing data.
Prevalence of antibiotic resistance among the 95 Staphylococcus aureus isolates
| Antibiotic classes | N (%) |
|---|---|
| Erythromycin | 33 (34.7) |
| Tetracycline | 33 (34.7) |
| Quinupristin-Dalfopristin | 27 (28.4) |
| Clindamycin | 21 (22.1) |
| Linezolid | 21 (22.1) |
| Rifampicin | 19 (20) |
| Gentamicin | 8 (8.4) |
| Ciprofloxacin | 8 (8.4) |
| 5 (5.3) | |
| Cefoxitin | 3 (3.2) |
| Oxacillin | 3 (3.2) |
| Sulfamethoxazole/trimethoprim | 1 (1.1) |
Figure 1Distribution of antibiotic resistance patterns of the 3 MRSA strains.
Notes: *Blackened cells indicate non-susceptibility and grey cells indicate susceptibility to the antibiotic. All MRSA isolates were susceptible to CIP, CLI, GEN, LNZ, SXT, RIF.
Abbreviations: CIP, ciprofloxacin; CLI, clindamycin; ERY, erythromycin; GEN, gentamicin; LNZ, linezolid; MUP, mupirocin; SXT, trimethoprim-sulfamethoxazole; QDA, quinupristin-dalfopristin; RIF, rifampicin; TET, tetracycline; CEF, cefoxitin; OX, oxacillin.
Cross-resistance of Staphylococcus aureus isolates
| Antimicrobials tested | na | % Resistance to: | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CIP | CLI | ERY | GEN | LNZ | MUP | SXT | QDA | RIF | TET | CEF | OX | ||
| 8 | - | 50 | 62.5 | 25 | 50 | 0 | 0 | 37.5 | 62.5 | 50 | 0 | 0 | |
| 21 | 19.1 | - | 66.7 | 14.3 | 57.1 | 0 | 0 | 47.6 | 38.1 | 52.4 | 0 | 0 | |
| 33 | 15.2 | 42.4 | - | 18.2 | 36.4 | 6.1 | 0 | 39.4 | 27.3 | 60.6 | 6.1 | 6.1 | |
| 8 | 25 | 37.5 | 75 | - | 25 | 0 | 12.5 | 37.5 | 25 | 50 | 0 | 0 | |
| 21 | 19.1 | 57.1 | 57.1 | 9.5 | - | 4.8 | 0 | 38.1 | 33.3 | 47.6 | 0 | 0 | |
| 5 | 0 | 0 | 40 | 0 | 20 | - | 0 | 80 | 0 | 40 | 40 | 40 | |
| 1 | 0 | 0 | 0 | 100 | 0 | 0 | - | 100 | 0 | 100 | 0 | 0 | |
| 27 | 11.1 | 37 | 48.2 | 11.1 | 29.6 | 14.8 | 3.7 | - | 29.6 | 48.2 | 7.4 | 7.4 | |
| 19 | 26.3 | 42.1 | 47.4 | 10.5 | 36.8 | 0 | 0 | 42.1 | - | 31.6 | 0 | 0 | |
| 33 | 12.1 | 33.3 | 60.6 | 12.1 | 30.3 | 6.1 | 3 | 39.4 | 18.2 | - | 6.1 | 6.1 | |
| 3 | 0 | 0 | 66.7 | 0 | 0 | 66.7 | 0 | 66.7 | 0 | 66.7 | - | 100 | |
| 3 | 0 | 0 | 66.7 | 0 | 0 | 66.7 | 0 | 66.7 | 0 | 66.7 | 100 | - | |
Notes: aNumber of resistant strains.
Abbreviations: CIP, ciprofloxacin; CLI, clindamycin; ERY, erythromycin; GEN, gentamicin; LNZ, linezolid; MUP, mupirocin; SXT, trimethoprim-sulfamethoxazole; QDA, quinupristin-dalfopristin; RIF, rifampicin; TET, tetracycline; CEF, cefoxitin; OX, oxacillin.
Figure 2Minimum spanning tree of the Staphylococcus aureus isolates typed by Multiple-locus variable number of tandem repeat analysis (MLVA).
Notes: *These isolates were methicillin-sensitive S. aureus (MSSA).
Abbreviations: LA, livestock associated; MT, MLVA type; MC, MLVA complex.